We wish to thank the following Representatives for working so very hard to get the Creating Hope Act – HR 4439 passed in the House of Representatives: G. K.Butterfield NC-1, Michael McCaul TX-10, Frank Pallone NJ-6, Greg Walden OR-2, and Anna Eshoo CA-18. Without their support and effort this legislation to have voucher incentives for drug development for #ChildhoodCancer and RarePediatricDieases would have expired. THANK YOU!
This successful program has created a pathway for small biotechs and even larger pharmaceutical companies to develop much needed drugs for pediatric rare diseases.
Since 2012 when the program originated, 24 rare pediatric disease drugs have been approved and the number of rare pediatric disease drugs that were in the drug development pipeline in 2019 was a 200% increase over 2016.
At no cost to taxpayers, The Creating Hope voucher program has created over $1 billion in incentives that improve the risk/return ratio of biotech and pharmaceutical companies making them more interested in pediatric rare disease drug development. When a company gets approval for a specific pediatric cancer or rare disease drug they receive a voucher from the FDA, which is transferable and it entitles the holder to put another drug through the FDA’s priority review process allowing them to get the drug to market much faster.